Scaling drug fill and finish processes can be a challenge for any pharma enterprise. Every formulation or step in production can present new challenges that require innovation, experience and new technical capabilities to overcome.
Read our recent blog for 5 steps to scaling out your fill/finish and read our recommendations for success
When the process is the product, the fill and finish steps are some of the most critical. Too often traditional manual processes lead to the risk of human error, which can cause potential quality issues and regulatory delays in getting finished products to the patient. In this blog, we explore how the digital data automatically generated by a closed fill and finish system can improve quality control and ensure better regulatory compliance.
Finia’s automated functions include mixing, aliquoting, removing air and sealing in an actively managed temperature-controlled environment that is gentle on cells. Packed with features that drive production and quality, Finia’s technology enables and empowers innovation to create greater patient benefits.